Annals of Family Medicine

NOVEMBER 20, 2024

The context: Immigrants, particularly those moving from lower to higher-income countries, often exhibit a heightened susceptibility to non-communicable diseases, such as Type 2 diabetes (T2D), which may manifest at an earlier age and present with different complications compared to the native population. 0.83, HR 0.70; 95% CI 0.65-0.76,

Complication 130

Complication Diabetes Individual Chronic Disease 130

Physician's Weekly

JUNE 17, 2025

As rates of obesity continue to rise alongside new therapeutic options, a team of researchers at the 85th Scientific Sessions of the American Diabetes Association (ADA) will present findings from PATHWEIGH , a pragmatic clinical trial designed to embed evidence-based obesity care directly into primary care workflows.

Primary Care 52

Primary Care Management Primary Care Physician Chronic Disease 52

Physician's Weekly

JUNE 18, 2025

Cost-sharing interventions and patient education can help improve access to GLP-1 receptor agonists for patients with obesity, according to an abstract presented at the AACE Annual Meeting 2025. Other Persistent Barriers & Potential Solutions In another article not presented at the meeting, Stephanie W.

Healthcare Professional 52

Healthcare Professional Insurance Manufacturing Healthcare 52

Annals of Family Medicine

NOVEMBER 20, 2024

These included people with lived/living experience of drug use, clinicians, researchers, government health department staff, and individuals from non-government organizations focusing on drug use. SETTING/DATASET: We conducted 14 semi-structured interviews with 16 key informants with insights into opioid use policy in Canada and Australia.

Primary Care 130

Primary Care Chronic Disease Management Government Chronic Disease 130

GeriPal

JULY 19, 2024

What should we use to screen individuals? Joe 18:38 Yeah, you know, it’s interesting, Soo, I’m doing a county by county visit here in Minnesota where I actually give a presentation on the basics of dementia and Alzheimer’s disease. Who should get it if anyone? What happens after they test positive?

Screening 119

Screening Primary Care Patient-Centered IT 119

Today's Hospitalist

JUNE 7, 2025

They presented a rapid clinical update Webinar in May 2025 hosted by the Society of Hospital Medicine. Laudenslager, is a chronic metabolic disease with highly complex pathophysiology—”and we are programmed to regain the weight we lose with lifestyle measures.”

Hospital 66

Hospital Management Diabetes Patients 66

GeriPal

OCTOBER 17, 2024

We talk about what is heart failure, particularly HFpEF, how we treat it (including the use of sodium–glucose cotransporter-2 inhibitors (SGLT2’s), and how we should apply guidelines to individual patients, especially those with multimorbidity who are taking a lot of other medications. But we’re not perfect individuals.

Primary Care 113

Primary Care Patient-Centered IT Patients 113